| Literature DB >> 26018293 |
Albert C Yang1, Jong-Ling Fuh, Norden E Huang, Ben-Chang Shia, Shuu-Jiun Wang.
Abstract
BACKGROUND: Researches to date on the association between headache and weather have yielded inconsistent results. Only a limited number of studies have examined the clinical significance of self-reported weather sensitivity. This study aimed to identify the difference in the association of headache with temperature between migraine patients with and without temperature sensitivity.Entities:
Mesh:
Year: 2015 PMID: 26018293 PMCID: PMC4446287 DOI: 10.1186/s10194-015-0533-5
Source DB: PubMed Journal: J Headache Pain ISSN: 1129-2369 Impact factor: 7.277
Summary of weather variables in year 2007 at Taipei City, Taiwan
| Variables | Whole year | Spring (Mar-May) | Summer (Jun-Aug) | Autumn (Sep-Nov) | Winter (Dec-Feb) |
|---|---|---|---|---|---|
| Temperature, °C | 23.6 ± 5.0 | 22.5 ± 4.4 | 29.1 ± 1.8 | 24.4 ± 3.3 | 18.5 ± 2.5 |
| Pressure, mmHg | 1012.2 ± 6.9 | 1012.7 ± 4.5 | 1005.2 ± 3.6 | 1012.1 ± 7.0 | 1019.2 ± 3.7 |
| Humidity, % | 75.6 ± 8.9 | 74.8 ± 8.8 | 74.8 ± 8.3 | 77.6 ± 8.5 | 75.1 ± 9.7 |
| Sunshine duration, hour | 3.9 ± 3.7 | 3.6 ± 3.9 | 4.9 ± 3.2 | 3.4 ± 3.7 | 3.5 ± 3.7 |
| Wind speed, m/s | 2.4 ± 1.3 | 2.1 ± 1.1 | 1.7 ± 1.1 | 3.3 ± 1.3 | 2.6 ± 1.1 |
Fig. 1Flow chart of time series analysis of headache and temperature data. Using empirical mode decomposition method, temperature time series was decomposed into an overall trend and various modes of fluctuations, termed intrinsic mode functions (IMFs). Each IMF represents a specific mode of temperature fluctuations. These IMFs were correlated with headache incidence data by multiple regression analysis to derive the explained variance in headache incidence by temperature
Demographic and clinical characteristics
| Characteristics | Total | Temperature sensitive | Temperature non-sensitive |
|
|---|---|---|---|---|
| N = 66 | N = 34 | N = 32 | ||
| Age, year | 43.3 ± 12.9 | 42.6 ± 12.3 | 44.0 ± 13.8 | 0.675 |
| Female, N (%) | 50 (75.8 %) | 27 (79.4) | 23 (71.9) | 0.671 |
| Age of onset, year | 24.5 ± 13.8 | 20.3 ± 9.8 | 29.1 ± 16.0 |
|
| Duration of illness, year | 18.8 ± 13.6 | 22.4 ± 13.1 | 14.9 ± 13.2 |
|
| Headache days per month, all severity | 6.3 ± 6.2 | 5.4 ± 5.0 | 7.2 ± 7.4 | 0.262 |
| Headache days per month, moderate or severe | 3.0 ± 3.2 | 2.1 ± 1.1 | 4.0 ± 4.2 |
|
| Acute treatment, N (%) | ||||
| Sumatriptan | 42 (63.6) | 22 (64.7) | 20 (62.5) | 1.000 |
| NSAIDs | 37 (56.1) | 22 (64.7) | 15 (46.9) | 0.225 |
| Preventive treatment, N (%) | ||||
| Propranolol | 40 (60.6) | 20 (58.8) | 20 (62.5) | 1.000 |
| Anti-convulsants | 20 (30.3) | 12 (35.4) | 8 (25.0) | 0.522 |
| Flunarizine | 13 (19.7) | 8 (23.5) | 5 (15.6) | 0.617 |
| Anti-depressants | 12 (18.1) | 7 (20.6) | 5 (15.6) | 0.841 |
| Either one | 56 (84.8) | 27 (79.4) | 29 (90.6) | 0.198 |
| Hypertension | 2 (3.0) | 1 (2.9) | 1 (3.1) | 0.498 |
| Diabetes | 6 (9.1) | 3 (8.8) | 3 (9.4) | 1.000 |
NSAIDs: Non-steroid anti-inflammatory drugs
*Comparisons between temperature sensitive and non-sensitive patients
Mean daily headache incidence (%) in each season in year 2007
| Groups | Whole year | Spring1 (Mar-May) | Summer2 (Jun-Aug) | Autumn3 (Sep-Nov) | Winter4 (Dec-Feb) |
| Post-hoc* |
|---|---|---|---|---|---|---|---|
| All patients (N = 66) | 22.5 ± 4.8 | 23.8 ± 4.9 | 21.3 ± 4.3 | 21.4 ± 4.8 | 23.6 ± 4.4 | <0.001 | 1 > 2; 1 > 3; 4 > 2; 4 > 3 |
| Temperature sensitive patients (N = 34) | 19.7 ± 6.6 | 19.3 ± 6.4 | 18.9 ± 5.9 | 19.1 ± 6.9 | 21.5 ± 7.1 | 0.031 | 4 > 3; 4 > 2; 4 > 1 |
| Temperature non-sensitive patients (N = 32) | 25.5 ± 6.5 | 28.5 ± 6.2 | 23.7 ± 5.8 | 23.8 ± 5.9 | 25.9 ± 6.9 | <0.001 | 1 > 2; 1 > 3; 1 > 4 |
*Headache incidence of four seasons was compared by ANOVA and LSD post-hoc test
Models of headache incidence and temperature IMFs
| Group | Model summary (R Square) | |||
|---|---|---|---|---|
| Spring | Summer | Autumn | Winter | |
| All Patients (N = 66) | NS | 0.096 ( | NS | 0.165 ( |
| Temperature Sensitive Patients (N = 34) | 0.060 ( | NS | NS | 0.292 ( |
| Temperature Non-Sensitive Patients (N = 32) | NS | 0.148 ( | NS | NS |
NS: non-significant (P > .0.05)